Related references
Note: Only part of the references are listed.Therapeutic opportunities for senolysis in cardiovascular disease
Mark Sweeney et al.
FEBS JOURNAL (2023)
Mitochondrial redox regulation and myocardial ischemia-reperfusion injury
Chwen-Lih Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)
Mitophagy Regulation Following Myocardial Infarction
Annie Turkieh et al.
CELLS (2022)
Interplay of Oxidative Stress and Necrosis-like Cell Death in Cardiac Ischemia/Reperfusion Injury: A Focus on Necroptosis
Adriana Adameova et al.
BIOMEDICINES (2022)
Intersection of autophagy regulation and circadian rhythms in the heart
Inna Rabinovich-Nikitin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)
Cardiac Remodeling and Repair: Recent Approaches, Advancements, and Future Perspective
Perwez Alam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release
Jillian N. Simon et al.
CIRCULATION (2021)
Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies
Kei Hayashida et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
New Insights Into the Role of Mitochondria Quality Control in Ischemic Heart Disease
Yanguo Xin et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury
Wylly Ramses Garcia-Nino et al.
LIFE-BASEL (2021)
Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective
Manli Zhou et al.
CARDIOLOGY (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury
Jia Huang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
The roles of PKC-δ and PKC-ε in myocardial ischemia/reperfusion injury
Li Chen et al.
PHARMACOLOGICAL RESEARCH (2021)
Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
Irina B. Krylova et al.
SCIENTIFIC REPORTS (2021)
Exploring the chemical space of protein-protein interaction inhibitors through machine learning
Jiwon Choi et al.
SCIENTIFIC REPORTS (2021)
Acute Myocardial Infarction Mortality Rates and Trends in Romania between 1994 and 2017
Sorin Ioacara et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Sha-Sha Cheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Peptide-based Interaction Proteomics
Katrina Meyer et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Cardiospecific Overexpression of ATPGD1 (Carnosine Synthase) Increases Histidine Dipeptide Levels and Prevents Myocardial Ischemia Reperfusion Injury
Jingjing Zhao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
DEVELOPING DRUGS FOR THE 'UNDRUGGABLE' There are up to 650,000 'undruggable' protein-protein interactions in the human interactome that can be potentially considered as novel therapeutic targets. How does the 'undruggable' become 'druggable'?
Abigail Sawyer
BIOTECHNIQUES (2020)
Spatiotemporal ATP Dynamics during AKI Predict Renal Prognosis
Shinya Yamamoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Macrocyclization of an all-d linear α-helical peptide imparts cellular permeability
Srinivasaraghavan Kannan et al.
CHEMICAL SCIENCE (2020)
Cardiac ischemia-reperfusion injury induces ROS-dependent loss of PKA regulatory subunit RIα
Kristofer J. Haushalter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Pros and Cons of Use of Mitochondria-Targeted Antioxidants
Egor Y. Plotnikov et al.
ANTIOXIDANTS (2019)
The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury
Andrey Kuznetsov et al.
ANTIOXIDANTS (2019)
A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats
Julio C. B. Ferreira et al.
NATURE COMMUNICATIONS (2019)
Current Mechanistic Concepts in Ischemia and Reperfusion Injury
Meng-yu Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area
Xu Ran et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
Myocardial Ischemia Reperfusion Injury: Apoptotic, Inflammatory and Oxidative Stress Role of Galectin-3
Suhail Al-Salam et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics
Nir Qvit et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Structures of the troponin core domain containing the cardiomyopathy-causing mutants studied by small-angle X-ray scattering
Tatsuhito Matsuo et al.
BIOPHYSICS AND PHYSICOBIOLOGY (2015)
Druggable protein-protein interactions - from hot spots to hot segments
Nir London et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
Phosphorylation of Cardiac Troponin I at Protein Kinase C Site Threonine 144 Depresses Cooperative Activation of Thin Filaments
Qun-Wei Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
Peptides mediating interaction networks: new leads at last
Victor Neduva et al.
CURRENT OPINION IN BIOTECHNOLOGY (2006)
Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole
Fabio Di Lisa et al.
CARDIOVASCULAR RESEARCH (2006)
Reperfusion-induced translocation of δPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation
EN Churchill et al.
CIRCULATION RESEARCH (2005)
Protein kinase C δ mediates cerebral reperfusion injury in vivo
R Bright et al.
JOURNAL OF NEUROSCIENCE (2004)
Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo
BB Roman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity
EM Burkart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Troponin I serines 43/45 and regulation of cardiac myofilament function
WG Pyle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
α-Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI
DE Montgomery et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and εPKC
L Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)